Answers are grounded in this paper and cite their sources.
Filariasis is a tropical disease with high morbidity rate due to lack of permanent cure. Here, we investigated specific filarial parasite antigens useful in treatment strategies for filariasis in areas where the chances of constant stimulations are at high peak. This study highlighted alterations in antigen recognition in the people living in endemic countries and receiving the orthodox treatments with diethylcarbamazine. We found that reinfection with L 3 stage in pre-DEC treated mouse sera recognises 62 kDa, 45 kDa and 32 kDa antigens, which was not present in control animal sera. Further investigation shows that 62 kDa antigen was present in microfilaria while 45 kDa and 31 kDa was part of adult stage. These findings demonstrated that reinfection during the course of DEC treatment unmask specific parasite antigen, which do not express during initial stage of infections. Our findings argued that mapping of these new antigens would be helpful in the development of treatment strategies through appropriate vaccine.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: